Connect with us
NGLFINE

NGL Fine-Chem Limited (NGLFINE) Stock Analysis

NGL Fine-Chem Limited is an Indian veterinary and animal health company manufacturing APIs and formulations for poultry and livestock globally. It exports active ingredients to regulated and semi-regulated markets. Animal protein demand and farm economics support volumes. It is listed on Indian stock exchanges.

Healthcare › Drug Manufacturers - General
₹3,041.30
+7.38% 1W  |  +105.70% 52W
Market Cap
1.9k CR
P/E Ratio
32.8
52W High
₹3602
52W Low
₹1271
Div. Yield
0.06%
Beta
0.9
50 DMA
₹2792.6
200 DMA
₹2669.5
Profit Margin
10.7%
Inst. Own.
0%
Trendline Analysis
🛑 HIT RESISTANCE₹3.5k₹3.2k₹2.9k₹2.5k₹2.2k18 May24 Jun03 Aug16 Sep13 Nov1.0L
Fundamentals
Profit & Loss
MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales808810091938995104120128149139159
YoY Sales growth+18%+22%+33%+28%+17%+1%-5%+15%+29%+43%+57%+34%+32%
Expenses6674848182848993103105128116131
Operating Profit14141691256111722212328
OPM %17%16%16%10%12%6%7%11%14%18%14%17%18%
Other Income34465-0-1625271
Interest0000011111111
Depreciation3333333455557
Profit before tax141416121311121321182422
Tax %25%30%23%22%26%-1%49%22%26%24%24%25%25%
Net Profit1010129101191016131816
EPS in Rs16.9616.2419.9414.9215.882.070.8714.9615.5925.4021.8429.7826.30
Growth — CAGR
Metric3Y5Y10Y
Revenue CAGR22.0%14.0%–
Profit CAGR37.0%-1.0%–
Shareholding Pattern
Promoters72.49%
FIIs0.04%
Public27.46%
NGLFINE
Holdings Analysis
Key strengths & risk signals
82
Overall
82
Fundamental
82
Technical
Risks (1)
NEGLIGIBLE DIVIDEND! 0.06% yield - little to no income.
Strengths (4)
UNDERVALUED! PEG of 1.00 indicates stock is cheap relative to growth.
BULLISH TREND! 50-day average (2792.6) is above 200-day average (2669.5) - positive signal.
EXCELLENT YEAR! Stock gained 105.7% in the last year.
BULLISH SENTIMENT! In last 30 days: 15 up days, 15 down days. Avg volume on up days: 11,838 vs down days: 4,445. Ratio: 2.66x
Fundamental & Technical Analysis
82Overall
82Fundamental
82Technical
Fundamental Breakdown
Growth Quality
30/30
Revenue CAGR: 21.8% (EXCELLENT, 15/15). Profit CAGR: 32.9% (EXCELLENT, 15/15).
Profit Margin
5/10
DECENT EFFICIENCY! 10.7% profit margin - acceptable profitability.
PEG Valuation
10/10
UNDERVALUED! PEG of 1.00 indicates stock is cheap relative to growth.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.06% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 26.46% public ownership - balanced ownership structure.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
10/10
BULLISH TREND! 50-day average (2792.6) is above 200-day average (2669.5) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (3041.3) is above both moving averages.
Trend Pattern
10/20
AT RESISTANCE! Stock is at key resistance level.
52W Performance
10/10
EXCELLENT YEAR! Stock gained 105.7% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 15 up days, 15 down days. Avg volume on up days: 11,838 vs down days: 4,445. Ratio: 2.66x
RSI
3/5
NEUTRAL! RSI at 57.3 - balanced momentum.
52W Range
4/5
UPPER HALF! Trading at 75.9% of 52W range - positive territory.
Momentum
3/5
MIXED MOMENTUM! Price growth is inconsistent - 7.4% (1 week), 6.1% (1 month), -11.9% (3 months).
Beta
4/5
BELOW MARKET! Beta of 0.90 - slightly less volatile than market.
NGLFINE
Concall / Investor Presentation
Earnings call transcripts & AI summaries
QuarterConcallSummary
Q4FY262026-05-30Concall PDF
Q2FY262025-11-20Concall PDF

Peer Comparison

Healthcare · Drug Manufacturers - General · 8 stocks
Industry peers
StockPriceP/EProfit MarginRevenue CAGR 5YProfit CAGR 5Y52W ChangeStock StrengthTrendlineYoY ProfitQoQ ProfitYoY RevenueQoQ Revenue
NGLFINE₹3,041.3032.810.7%21.8%32.9%+105.7%82 HIT RESISTANCE+100.0%+36.3%+33.6%-6.7%
SAIPARENT₹496.9088.13.7%57.9%48.3%+24.7%68 APPROACHING SUPPORT+64.1%-33.5%+264.3%+9.1%
KOPRAN₹289.1035.55.0%7.0%-16.0%+84.3%66 CONSOLIDATING UP-144.3%-34.5%+79.2%+37.2%
TTKHLTCARE₹938.504.730.1%5.9%-53.2%-15.8%58 BREAKDOWN–+946.9%–-9.4%
SMSPHARMA₹508.1040.212.0%19.3%–+80.3%73 APPROACHING RESISTANCE+57.7%+90.9%+30.4%+52.7%
CORONA₹2,329.7068.113.3%16.6%29.7%+64.6%80 BREAKOUT+15.3%+33.1%+22.2%+25.0%
SENORES₹1,174.6038.618.6%159.1%139.2%+48.0%72 BREAKDOWN+21.9%+28.7%+25.0%+6.7%
SANOFI₹3,301.4020.720.0%-12.6%-19.3%-27.9%57 BREAKOUT–+39.8%–+12.3%
Data from TradeAlone · Updated daily